IPOPLUS

2,136.6

-20.1 -0.93%

17 Jun 2026

NSE Listed · Pharmaceuticals

Glenmark Pharmaceuticals (GLENMARK)

Volume: 16,226Avg Vol 1W: 1,11,034Avg Vol 1M: 3,97,69152W Range:1,5892,474
₹2,136.6 0.93%
Key Ratios
Updated 3h ago
Market Cap₹61,328 Cr
Current Price₹2,136.6
Previous Close₹2,156.7
High / Low (52w)₹2,474 / ₹1,589
Volume16,226
Avg Vol (1W)1,11,034
Avg Vol (1M)3,97,691
Stock P/E41.5
Book Value₹372.51
Dividend Yield0.12%
ROE28.08%
ROA6.84%
Revenue (TTM)
Revenue Growth12.77%
Profit Margin8.15%
Total Debt₹513 Cr
Shares Outstanding28 Cr
Face Value₹1
EPS (TTM)₹10.68
P/B6.3
Debt / Equity0.06
50 DMA₹2,263.96
200 DMA₹2,166.35
Day change-0.93%
Price Chart
2,136.6 14.67% · 1Y
2426180861.0L
2025-10-21
2026-06-16

20-day avg volume: 3.3L shares

Pros
  • Healthy return on equity of 28.1%.
  • Company is almost debt-free.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹3,771 Cr₹3,901 Cr₹6,047 Cr₹3,264 Cr₹3,256 Cr₹3,388 Cr₹3,434 Cr₹3,244 Cr₹3,063 Cr₹2,507 Cr₹3,207 Cr₹3,036 Cr₹3,001 Cr₹3,100 Cr₹3,018 Cr₹2,777 Cr₹3,019 Cr₹3,173 Cr₹3,147 Cr₹2,965 Cr₹2,860 Cr₹2,787 Cr₹2,952 Cr₹2,345 Cr₹2,767 Cr
EBITDA₹804 Cr₹760 Cr₹2,419 Cr₹477 Cr₹448 Cr₹509 Cr₹521 Cr₹502 Cr₹1,126 Cr₹-310 Cr₹323 Cr₹315 Cr₹220 Cr₹393 Cr₹420 Cr₹468 Cr₹439 Cr₹588 Cr₹454 Cr₹519 Cr₹421 Cr₹430 Cr₹417 Cr₹423 Cr₹384 Cr
Net Profit₹301 Cr₹403 Cr₹610 Cr₹47 Cr₹5 Cr₹348 Cr₹354 Cr₹340 Cr₹-1,218 Cr₹-351 Cr₹-82 Cr₹150 Cr₹-428 Cr₹273 Cr₹260 Cr₹193 Cr₹156 Cr₹222 Cr₹258 Cr₹307 Cr₹234 Cr₹248 Cr₹234 Cr₹254 Cr₹220 Cr
EPS10.6814.2821.621.660.1612.3312.5512.06-43.17-12.45-2.95.31-15.189.669.236.825.517.869.1310.868.298.88.2997.81
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹13,435 Cr₹12,653 Cr₹11,872 Cr₹12,472 Cr₹10,994 Cr₹10,801 Cr
EBITDA₹1,979 Cr₹1,453 Cr₹1,355 Cr₹2,000 Cr₹1,691 Cr₹1,441 Cr
Net Profit₹1,047 Cr₹-1,502 Cr₹297 Cr₹942 Cr₹970 Cr₹776 Cr
EPS37.11-53.2210.5333.3734.3827.5
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹16,050 Cr₹14,359 Cr₹19,372 Cr₹17,083 Cr₹15,604 Cr₹14,685 Cr
Total Liabilities₹7,200 Cr₹6,511 Cr₹9,532 Cr₹7,645 Cr₹8,539 Cr₹8,615 Cr
Equity₹8,849 Cr₹7,848 Cr₹9,839 Cr₹9,438 Cr₹7,064 Cr₹6,070 Cr
Total Debt₹513 Cr₹0 Cr₹3,852 Cr₹2,572 Cr₹3,889 Cr₹4,043 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹-147 Cr₹782 Cr₹1,266 Cr₹1,667 Cr₹1,641 Cr₹1,859 Cr
Investing₹2 Cr₹4,561 Cr₹-528 Cr₹-333 Cr₹-675 Cr₹-784 Cr
Financing₹787 Cr₹-3,906 Cr₹-77 Cr₹-520 Cr₹-442 Cr₹-445 Cr
Free Cash Flow₹-147 Cr₹782 Cr₹1,266 Cr₹1,667 Cr₹1,641 Cr₹1,859 Cr
Shareholding
Promoter 46.65% Institutions 39.63% Public 13.68%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search